Leading the finance and strategic effort with new CEO and management team to transform a R&D focused biotech with a potential blockbuster biologic candidate targeting wet AMD in late-stage pivotal trials into a global innovative commercial-stage biopharma • Spearhead the capital financing plan to fund two large, global pivotal Phase 3 wet AMD trials within seven months of hire rating over $235 million• Expand and upgrade relationships with sell-side research analysts, bankers, and investors• Lead the development of a comprehensive financial plan, ensure accurate and timely financial reporting across two jurisdictions, dual exchanges and three accounting standards, and oversee capital allocation to support strategic initiatives• Enhance and build the finance and IT organization and staff, implement formalized procedures and controls to improve accounting and efficiencies, implement budgeting process and accountability, and initiate SOX compliance protocols• Build, mentor, and lead high-performing teams, while fostering a culture of continuous improvement, collaboration, flexibility, and excellence. • Overhaul and upgrade IT and security platform plus engage new IT service provider

Advising and working on strategy, operations, finances, and fundraising as key advisor to the senior management team.Acting as CFO-in-residence.

Developed and executed a strategic, operational, and financial repositioning of an innovative commercial-stage ophthalmology biopharma with a refocused pipeline Responsible for directing the financial activities & performance, capital allocation, and budgeting.Worked with CEO and Board on strategy, organic growth, and business development.Implemented financial discipline and analysis, resulting in a ~30% reduction in cash burn and creating a path to profitability in 2024.Communicated, interacted, and enhanced relationships with Wall Street analysts and investorsManaged and optimized capital structure, including implementing a plan to refinance a $316 million convertible, which maximized the cost of capital and increased financial flexibility.Led the negotiations, diligence, negotiation, closing, and integration of the $955+ million all-cash acquisition of Aerie by Alcon.

Partner with CEOs, CFO, Boards, and senior executives to help develop strategic initiatives and growth plans, and effect implementation.Develop and execute financing plans and capital structure objectives, assist in securing funding, and enhance investor engagement and investor relations.Advise clients regarding strategic plans, operations, financings & capital structure, merger & acquisitions, JVs, and partnerships as an independent investment banker, advisor, and consultant.Build and manage relationships with CEOs, CFO, Boards, senior executives, investors, and other outside advisors offering valued-added advice, strategy, deal execution, and connections.Create operating procedures and metrics to improve accounting, reporting and profitability, support business development activities, and prepare budgets and projections.Senior investment banker, advisory, and finance professional with deep expertise in healthcare and a 25+ year track record of success of delivering solutions.Acted as a strategic advisor and executive-in-residence for multiple biotechs assisting on financing, partnerships, operations, and strategyServing CFO-in-residence for tech start-up assisting with strategy, accounting & finance procedures, invoicing and payments, capital structure, compensation, valuations, and fundraising.Re-launched the healthcare investment banking franchise at a boutique firm focused on innovative medicines, as Managing Director and Head of Healthcare Investment Banking.

Led and ran HSBC's healthcare investment banking franchise in the US and North America.Generated, grew and strengthened client relationships with US/North American-based biopharma, medical technology, and healthcare services companies.Offered a full range of investment banking services including strategy, merger & acquisition advice, capital markets solutions, and debt & equity execution and acquisition financing.Up-tiered existing corporate banking relationships, developed new clients and earned investment banking mandates by providing value-added advice and execution, particularly regarding M&A, capital structure and acquisition financing.Directed the global resources of HSBC to our healthcare clients.Coordinated across and worked with functional and geographic groups to provide superior advice and deal execution for our healthcare clients.Leveraged and managed HSBC's multi-billion lending commitments and commercial banking relationships with US-based healthcare companies.Managed and supported five corporate healthcare banking teams in Global Banking serving over 50 larger clients and worked with various relationship bankers in Commercial Banking & Markets serving private and small/mid-cap firmsExpanded and deepened private equity sponsor relationships to secure and execute LBO mandates.Earned direct, event-driven revenue in $25-$35mm range.Developed and mentored a healthcare banking team in the US.Supervised and responsible for US healthcare budget finances, P&L, loan book, and staffing

Co-headed the biopharma investment effort at FBR with mandate to build a newly relaunched franchise.Originated, developed and grew client relationships with biotech and pharmaceutical companies, focusing mainly on small and midcap biopharmas.Advised senior management executives and Board of Directors on capital structure, financings alternatives and merger & acquisitions.Earned and successfully completely mandates for IPOs, follow-on equity offerings and acquisitions.Recruited, built, trained and mentored a team across multiple experience levels and functions.

Originated, managed and supported key client relationship in the healthcare sector with a key focus on merger and acquisitions.Advised senior management executives and Board of Directors on merger & acquisitions, capital structure and financings alternatives.Provided transaction advice, solutions and execution tailored to needs of the client across a broad spectrum of M&A, defense, licensing, JVs, LBOs and equity, convert & debt financing product offerings.Won and successfully executed sell and buy side acquisitions as well as several financing offerings.Managed deal teams and actively worked with internal corporate teams and external advisors.

Provided advisory and financing investment banking services in the healthcare sector.Managed key client relationships with healthcare companies by providing advice to senior management and Boards regarding strategic, financing and capital markets alternatives with focus on the life sciences sector.Actively involved in client and business origination focusing on marketing and engaging new clients as well as continuing to enhance existing relationships.Offered experience in all forms of advisory, including domestic and cross-border M&A, complex and tax-efficient structuring, defense advisory, hostile takeovers and leveraged buyout.Provided expertise across all capital markets products, including equity, private placements, convertibles, credit facilities, investment grade debt and leverage finance.Led transaction execution by managing internal cross-functional teams and interfacing with company management, counsel and other deal representatives.

Investment banker at Macquarie Capital Advisors working in the Diversified Industrials Group.Served as an senior M&A banker assisting industry teams in business development and deal execution by providing M&A tactic and structuring advice, deal management, negotiation and valuation work.Launched electrical and electronics sector coverage as a senior member of a team with P&L responsibilities.Created and implemented M&A solutions on several Macquarie-owned investments.

Senior investment banker in the Global Healthcare Group.Developed and strengthened client relationships by offering strategic, financing and capital markets advice to executive management with focus on the biopharmaceutical, medical technology and life sciences sectors.Executed all aspects of strategic and capital raising transactions, including negotiating terms and purchase agreements, coordinating with internal product groups and interacting with company management, counsel and other deal advisors.Promoted multiple levels, to a senior relationship client manager P&L responsibilities.Earned multiple mandates and successfully completing financing and M&A transactions for corporate clients.

Investment banker in the Global Healthcare Group.Managed transaction execution in the life sciences, biopharmaceutical, healthcare services and medical devices sectors.Executed all phases of transactions, including client management, deal execution, financial analysis and drafting.Coordinated with teams in investment banking, equity and debt capital markets and corporate clients.Developed and enhanced client relationships and assisted with new business activitiesSpecific experience in M&A, equity and equity-linked offerings, high yield and investment grade debt financings and leveraged buyouts.